Clinical trial
A Bioequivalence Study of HR20031 Tablet in Healthy Subjects
NCT05682495 is registered in ClinicalTrials.gov with Shandong Suncadia Medicine Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Bioequivalence Study of HR20031 Tablet in Healthy Subjects
- Lead sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2023
- Completion date
- April 4, 2023
- Enrollment
- 96 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes